
Seattle biotechnology startup Blaze Bioscience has raised $8.5 million to continue developing technologies that are designed to help surgeons more easily identify cancer cells in the body. Total funding in the company, with operations in the South Lake Union area of Seattle, now stands at $9.8 million. Blaze said that the money came from individual… Read More…































Most commented